Gbiologics
This biotechnology company develops protein therapeutics targeting rheumatoid arthritis and KRAS-mutant cancers through an open innovation strategy. Their dual-action antibiotic drugs aim to alleviate symptoms of rheumatoid arthritis while addressing osteoporosis complications and inducing apoptosis in cancer cells.
Traction –/10
성남시, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biotechnology company develops protein therapeutics targeting rheumatoid arthritis and KRAS-mutant cancers through an open innovation strategy. Their dual-action antibiotic drugs aim to alleviate symptoms of rheumatoid arthritis while addressing osteoporosis complications and inducing apoptosis in cancer cells.